These studies suggest that determination of MGMT methylation status maybe an important factor in determining which glioblastoma patients should receive chemoradiotherapy (Gorlia et al, 2008), but its prognostic significance in the routine clinical setting is not clearly established. This evidence concerns the gene MGMT and glioblastoma.